Cargando…

The impact of clinical and translational research on the quality of life during the metastatic colorectal cancer patient journey

The journey of metastatic colorectal cancer patients is complex and challenging, requiring coordination and collaboration between multiple healthcare providers. Understanding patients’ needs, fears, feelings, concerns, and behaviors is essential for providing individualized patient-centered care. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodriguez Castells, Marta, Baraibar, Iosune, Ros, Javier, Saoudi, Nadia, Salvà, Francesc, García, Ariadna, Alcaraz, Adriana, Tabernero, Josep, Élez, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614292/ https://www.ncbi.nlm.nih.gov/pubmed/37909013 http://dx.doi.org/10.3389/fonc.2023.1272561

Ejemplares similares

Encorafenib plus cetuximab for the treatment of BRAF-V600E-mutated metastatic colorectal cancer
por: Ros, Javier, et al.
Publicado: (2022)

Advances in immune checkpoint inhibitor combination strategies for microsatellite stable colorectal cancer
por: Ros, Javier, et al.
Publicado: (2023)

Combined Treatment with Immunotherapy-Based Strategies for MSS Metastatic Colorectal Cancer
por: Baraibar, Iosune, et al.
Publicado: (2021)

Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications
por: Saoudi González, Nadia, et al.
Publicado: (2023)

Immunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers
por: Ros, Javier, et al.
Publicado: (2023)

Liver transplantation in metastatic colorectal cancer: are we ready for it?
por: Ros, Javier, et al.
Publicado: (2023)

Correction To: Liver transplantation in metastatic colorectal cancer: are we ready for it?
por: Ros, Javier, et al.
Publicado: (2023)

Molecular subtypes and the evolution of treatment management in metastatic colorectal cancer
por: Martini, Giulia, et al.
Publicado: (2020)

BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer
por: Ros, Javier, et al.
Publicado: (2021)

Sex and gender perspectives in colorectal cancer
por: Baraibar, I., et al.
Publicado: (2023)

Impact of the COVID-19 pandemic in the early-onset colorectal cancer
por: Baraibar, Iosune, et al.
Publicado: (2023)

Current and emerging anti-angiogenic therapies in gastrointestinal and hepatobiliary cancers
por: Saoudi González, Nadia, et al.
Publicado: (2022)

A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy
por: Élez, Elena, et al.
Publicado: (2022)

332P Impact of the COVID-19 pandemic in the early-onset colorectal cancer (EOCRC)
por: Baraibar Argota, I., et al.
Publicado: (2022)

Translational analysis and final efficacy of the AVETUX trial – Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer
por: Tintelnot, Joseph, et al.
Publicado: (2022)

Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer
por: Serna, Garazi, et al.
Publicado: (2019)

Metabolic Reprogramming Helps to Define Different Metastatic Tropisms in Colorectal Cancer
por: Montero-Calle, Ana, et al.
Publicado: (2022)

SEOM-GEMCAD-TTD clinical guidelines for the systemic treatment of metastatic colorectal cancer (2022)
por: Fernández Montes, Ana, et al.
Publicado: (2023)

Perspectives on Immunotherapy of Metastatic Colorectal Cancer
por: Dai, Yongjiu, et al.
Publicado: (2021)

QTWiST analysis of the RECOURSE trial of trifluridine/tipiracil in metastatic colorectal cancer
por: Tabernero, Josep, et al.
Publicado: (2017)

Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer
por: Elez, E, et al.
Publicado: (2016)

Biomarkers in Colorectal Cancer: The Role of Translational Proteomics Research
por: Alves Martins, Bruno Augusto, et al.
Publicado: (2019)

Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer
por: Martini, G., et al.
Publicado: (2023)

RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF(V600E) metastatic colorectal cancer
por: Elez, Elena, et al.
Publicado: (2022)

Current Treatments of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitors—2020 Update
por: Jung, Gerhard, et al.
Publicado: (2020)

Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS‐mutant metastatic colorectal cancer
por: Elez, Elena, et al.
Publicado: (2019)

Optimizing the first-line treatment for metastatic colorectal cancer
por: Cherri, Sara, et al.
Publicado: (2023)

Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer
por: Ciardiello, Davide, et al.
Publicado: (2021)

KRAS Mutational Regression Is Associated With Oligo-Metastatic Status and Good Prognosis in Metastatic Colorectal Cancer
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target
por: Román, Marta, et al.
Publicado: (2018)

The Role of Pre-treatment Inflammatory Biomarkers in the Prediction of an Early Response to Panitumumab in Metastatic Colorectal Cancer
por: Lasagna, Angioletta, et al.
Publicado: (2022)

Phase II Open-Label Study to Assess Efficacy and Safety of Lenalidomide in Combination with Cetuximab in KRAS-Mutant Metastatic Colorectal Cancer
por: Siena, Salvatore, et al.
Publicado: (2013)

The Prognostic Impact of the Metastatic Lymph Nodes Ratio in Colorectal Cancer
por: Zhang, Chi-Hao, et al.
Publicado: (2018)

Current Therapeutic Strategies in BRAF-Mutant Metastatic Colorectal Cancer
por: Grassi, Elisa, et al.
Publicado: (2021)

Microsatellite Instability and Metastatic Colorectal Cancer – A Clinical Perspective
por: Buchler, Tomas
Publicado: (2022)

Current concepts of anti-EGFR targeting in metastatic colorectal cancer
por: Doleschal, Bernhard, et al.
Publicado: (2022)

The opportunity of patient-journey studies for academic clinical research in oncology
por: Perrone, Francesco, et al.
Publicado: (2021)

Bispecific antibodies in multiple myeloma treatment: A journey in progress
por: Cho, Shih-Feng, et al.
Publicado: (2022)

Germline Profiling and Molecular Characterization of Early Onset Metastatic Colorectal Cancer
por: Xu, Ting, et al.
Publicado: (2020)

Perspectives in the Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer Patients
por: Rosati, Gerardo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6ko65s908sa20pipjtvjbrglj9